Literature DB >> 9605981

Development and evaluation of a chromatographic procedure for partial purification of substance P with quantitation by an enzyme immunoassay.

W P Fehder1, W Z Ho, D E Campbell, W W Tourtellotte, L Michaels, J R Cutilli, M Uvaydova, S D Douglas.   

Abstract

We have developed a simple chromatographic procedure for the partial purification of substance P (SP) from acidified plasma and serum samples. We have evaluated a sensitive antigen competition enzyme immunoassay (EIA) for the quantitation of SP. The chromatographic procedure has recovery efficiencies ranging from 94.8 to 125%. The immunoreactivity of unknown amounts of purified SP subjected to the preparative procedure yielded a coefficient of variance of 9.4%. The EIA yielded reproducible standard curves having an interassay (n = 8) correlation coefficient of 0.984. The evaluation of normal adult control serum yielded a mean value of 51 pg/ml (range, 35 to 61 pg/ml). The evaluation of 3.33 x concentrates of serum-derived partially purified SP provided uncorrected SP values of 117 to 201 pg/ml, which fell within the midpoint of the three-decalog standard curve. These studies indicate that both the preparative and quantitative procedures are required for the detection of SP in plasma or serum samples collected from patients with several clinical disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605981      PMCID: PMC104514          DOI: 10.1128/CDLI.5.3.303-307.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

2.  Amino-acid sequence of substance P.

Authors:  M M Chang; S E Leeman; H D Niall
Journal:  Nat New Biol       Date:  1971-07-21

3.  Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction.

Authors:  P Rameshwar; P Gascón
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

4.  Modification of lymphocyte traffic by vasoactive neurotransmitter substances.

Authors:  T C Moore
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

5.  [Changed levels of substance P and somatostatin in HIV-positive children].

Authors:  C Azzari; M E Rossi; M Resti; A L Caldini; L Lega; L Galli; E Fico; A Vierucci
Journal:  Pediatr Med Chir       Date:  1992 Nov-Dec

6.  Specific stimulation of human T lymphocytes by substance P.

Authors:  D G Payan; D R Brewster; E J Goetzl
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

Review 7.  Substance P and stress-induced changes in macrophages.

Authors:  C Chancellor-Freeland; G F Zhu; R Kage; D I Beller; S E Leeman; P H Black
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

8.  In vitro stimulatory effect of substance P on hematopoiesis.

Authors:  P Rameshwar; D Ganea; P Gascón
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

9.  Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells.

Authors:  A M Stanisz; R Scicchitano; P Dazin; J Bienenstock; D G Payan
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

10.  Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.

Authors:  C M Fernández-Rodriguez; J Prieto; J Quiroga; J M Zozoya; A Andrade; M Núñez; B Sangro; J Penas
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

View more
  5 in total

1.  Alliteration in medicine: a puzzling profusion of p's.

Authors:  G F Hayden
Journal:  BMJ       Date:  1999 Dec 18-25

2.  Monocytes/macrophages in diagnosis and immunopathogenesis.

Authors:  S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Measurement of plasma-derived substance P: biological, methodological, and statistical considerations.

Authors:  Donald E Campbell; Nancy Raftery; Richard Tustin; Nancy B Tustin; Michelle L Desilvio; Avital Cnaan; Pyone Pyone Aye; Andrew A Lackner; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2006-09-13

4.  Role of MUC5AC in the pathogenesis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Jason S Debley; Federico M Farin; William R Henderson
Journal:  J Allergy Clin Immunol       Date:  2007-02-26       Impact factor: 10.793

5.  Novel method for determination of substance P levels in unextracted human plasma by using acidification.

Authors:  Donald E Campbell; Paula Bruckner; Nancy B Tustin; Richard Tustin; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2009-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.